Braeburn cancels IPO plans

Braeburn Pharmaceuticals Inc. (Princeton, N.J.) said Thursday it has decided against conducting an IPO, citing market conditions. The company is the first biopharma this year to scuttle a planned IPO on NASDAQ.

The company said "significant available capital" and a series of upcoming milestones contributed to its decision...